Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Shigella flexneri 2a O-antigen (S. flexneri 2a O-antigen)
- Target
- S. flexneri 2a O-antigen
- Molecular classification
- Polysaccharide, Lipopolysaccharide component, Antigen
01
Overview
The Shigella flexneri 2a O-antigen is a serotype-specific polysaccharide component of the lipopolysaccharide (LPS) on the outer membrane of S. flexneri serotype 2a, a major cause of bacillary dysentery. The O-antigen is critical for bacterial virulence, immune evasion, and serospecificity. It is a branched pentasaccharide composed of rhamnose, N-acetylglucosamine, and glucose, variably modified by glucosylation and O-acetylation. Chain length, regulated by Wzz proteins, affects motility and complement resistance. The O-antigen is a target for protective antibodies and a basis for conjugate vaccine development.
- Other names
- S. flexneri serotype 2a O-antigenShigella flexneri 2a LPS O-antigenO-antigen S. flexneri 2aGroup B O-antigen
02
Mechanism of action
N/A
03
Biological functions
Serospecificity determinationImmune evasionBacterial virulenceCell adhesionOuter membrane stabilization
04
Disease associations
Bacillary dysenteryShigellosisInfection
05
Safety considerations
Potential for immune escape through O-antigen modificationChallenge of developing broadly protective vaccines due to serotype diversity
Beyond the preview
Go deeper on Shigella flexneri 2a O-antigen (S. flexneri 2a O-antigen).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shigella flexneri 2a O-antigen (S. flexneri 2a O-antigen).